Search results for: COVID-19 Research
Filter search results
Join OHE at ISPOR: MCDA, Risk Sharing and Value-Based Pricing
4 October 2011
…14th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will be held in Madrid on 5-8 November. Profs Towse and Devlin OHE’s Nancy Devlin…
Pharmaceuticals in seven nations
1 May 1985
…Federal Republic of Germany, OHE is funded entirely by the Association of the British Pharmaceutical Industry and MPS by seven research-based companies in Germany. The Report describes the modern research-based…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
This post reviews OHE’s activities in September 2011 that contributed to advancing thought and stimulating innovative ideas in its three key research areas: financing and delivery of health care, HTA…
NICE’s Social Value Judgments: A Closer Look at Progress
30 May 2012
…“NICE has explicitly identified so many of the issues and opened them up for research and public discussion must be counted as remarkable pioneering achievements not to be found elsewhere…
Prospective Observational Studies: Whether, When and How to Use
18 June 2012
OHE’s Adrian Towse is co-author on the recent report by the ISPOR Good Research Practices Task Force on assessing comparative effectiveness using prospective observational studies. Prof Towse OHE’s Adrian…
Mireia Jofre-Bonet
8 January 2019
…St George’s, University of London. She is a member of the Health Economics Study Group and the Royal Economic Society and serves on the UK Research and Innovation Expert Panel. …
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
1 March 2019
OHE Research Paper 19/02: The combination of rising drug costs in the US and increasing financial stress for individual patients has triggered intense national concern. One target has come under…
How to Analyse EQ-5D Data? Methods for Analysing and Reporting EQ-5D Data: The Indispensable New Guide
8 December 2020
…with EQ-5D Data” written by Professor Nancy Devlin (OHE’s then Director of Research, now Senior Visiting Fellow). Nancy’s message immediately resonated in the health economics world, generating a very high number…
OHE Study on Pharmaceutical R&D Costs Released
3 December 2012
How much it costs to research and develop a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter not just because of…